Abbott Named One of the Top 10 Companies in Calvert Diversity Survey
Abbott (NYSE: ABT) has been named one of the Top 10 companies for diversity in a new survey conducted by Calvert Group.
Abbott (NYSE: ABT) has been named one of the Top 10 companies for diversity in a new survey conducted by Calvert Group. The survey reviewed the diversity programs, policies and performance of all companies in the Standard & Poor's 100 Index (S&P 100). Abbott received a score of 90 out of 100, which was significantly higher than the average scores of 72 for its industry sector and 68.5 for all S&P 100 companies.
In addition to being included on the Calvert survey, Abbott was named to DiversityInc magazine's 2010 list of the Top 50 Companies for Diversity, and to Hispanic Business magazine's Diversity Elite 60 Top Companies for Hispanics earlier in 2010. It was the seventh year Abbott has been included on the DiversityInc list, and the fourth year the company has been included on the Hispanic Business list. The company also was recently named one of the 100 Best Companies by Working Mother magazine; it was the tenth consecutive year the company has been included o
Related News
-
News Women in Pharma: Moving beyond discussions and into best practice at CPHI Milan
In this second CPHI Milan special of our monthly series, we cover the key takeaways from the Diversity & Wellbeing track held on October 10, 2024. -
News CPHI Pharma Awards 2024: Meet the winners from the CPHI Celebration
This year we had a lot to celebrate, the 35th Anniversary of CPHI, and our esteemed award winners, of which we included two additional categories this year, the Future Leader award, and Woman of the Year award. -
News CPHI Milan 2024 - From the Floor
Milan and CPHI welcome you to 2024 CPHI Milan! As we celebrate the 35th edition of our flagship CPHI show, editors Vivian Xie and Lucy Chard bring you the latest from the show floor, conference sessions, and innovative solutions from all exhibitors, at... -
News Women in Pharma: C-Suite Journeys in Leading Diversity
In this CPHI Milan special of our monthly series, we sit down with our panel of C-suite executives speaking on the ‘Leading with Diversity: The CEO Journey’ panel at this year’s show. -
News Women in Pharma: A leader's approach to diversity advocacy
In our monthly series on women in the pharmaceutical industry, we interview leading experts in the pharmaceutical supply and value chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Mentorship Programme - building a stronger pharma community
CPHI has a reputation for bringing the pharma industry together, creating a space where partnerships can be formed and nurtured, and relationships can be developed and cultivated between all industry actors. These collaborations encourage growth in the... -
News CPHI Podcast Series: Why we need to consider women in clinical trials
The latest episode of the CPHI Podcast Series with Lucy Chard covers women's health, specifically women's representation in clinical trials, the associated bias, and the impacts on health for this population. -
News Novartis and Viatris latest facing lawsuit over HeLa cell misuse
Global pharmaceutical companies Novartis and Viatris are the latest hit with a lawsuit claim pertaining to alleged misuse of the ‘HeLa’ cell line from the estate of woman whose cancerous tissue cells were taken without consent.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance